Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from MIRA Pharmaceuticals, Inc. ( (MIRA) ).
On October 16, 2025, MIRA Pharmaceuticals, Inc. sold 1,751,000 shares of its common stock at an average price of $2.19 per share, a 66% premium to the prior day’s close, through its at-the-market equity offering facility. The sale, facilitated by Rodman & Renshaw via the StockBlock platform, generated gross proceeds of approximately $3,835,485, excluding fees and expenses, and did not include any warrants.
More about MIRA Pharmaceuticals, Inc.
Average Trading Volume: 1,283,286
Technical Sentiment Signal: Sell
For a thorough assessment of MIRA stock, go to TipRanks’ Stock Analysis page.